CEO: John F. Crowley

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.


Key numbers

Market Capitalization:2652572100
Shares Outstanding: 254810000
Float: 247703604
Next Earning Date:2020-02-26
TTm EPS: -1.5735
TTm Dividend Rate:
200 days moving average:10.77
50 days moving average: 9.75
One day percent Change: -1.42



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,